Cancer Survivors
Testimonials Written by Cancer Patients 

  What You Must Know
List of important topics that each Cancer Patient should be aware of
What is the 5 year Survival Rate for Chemotherapy?
Per this 2004 published article from the Journal of Clinical Oncology, research scientists performed a study to determine the long term benefit of Chemotherapy based on how many patients were still alive after 5 years. The results were miserable. Based on all of the published studies they could review in Australia and the US respectively, the 5 YEAR SURVIVAL RATE in Australia was 2.3% and in the United States, it was even lower at 2.1%.

Based on this data from 1998, these scientists concluded "it is clear that cytotoxic chemotherapy only makes a minor contribution to cancer survival."
Stage 4 Cancer Study with Poly MVA & Low Dose Chemo
1,000 Stage 4 Cancer Patients - received Low Dose Chemo & Poly MVA  
Based on the Stage 4 Cancer Study results below and the myriad of cancer testimonials found on this website, each cancer patient will better understand why adding Poly MVA (LAPd) to their Integrative Cancer Protocol may help to dramatically increase their survival time while minimizing the toxic side effects associated with Chemotherapy "only" protocols.

Oncologist Dr. James Forsythes' Stage 4 Cancer Studies to see how the combination of LOW DOSE Chemotherapy (20% of standard of care dose) and Poly MVA (LAPd) resulted in 5 Year Survival Rates that are far superior (below) than the 5 year survival results (listed above) for Chemotherapy alone.

These remarkable results are further verified and supported by the Published Articles below which can be found in full on Pub Med by clicking on each of the LINKS below.
71% Survival Rates  after 5 Years & 10 Months for over 16 Types of Cancer
Antioxidants significantly Benefit Cancer Patients
when taken with Chemotherapy & Radiation
#1 - Antioxidants DO NOT Interfere with Chemo & Radiation

#2 - Antioxidants reduce Chemo Toxicity & improve Survival

Poly MVA ORAC Value
The Oxygen Radical Absorbance Capacity (known as the ORAC value, or ORAC score) is a method developed by scientists at the National Institute of Health and Aging (NIH) to measure the antioxidant capacity of different foods and compounds.

Whilst the exact relationship between the ORAC value of a food and its health benefit has not been fully established, it is generally believed that foods with higher ORAC scores have greater antioxidant capacity, and more effectively
neutralise/scavenge harmful free radicals.

According to the free-radical theory of ageing and disease,
a high antioxidant intake from foods/compounds, will slow the oxidative processes and free radical damage that contributes to age-related degeneration and disease.

ORAC Value Comparisons

Brunswick Labs, Wareham, MA

(expressed as Trolox equivalent per gram)
Vitamin C  Lipoic Acid   Melatonin  Poly-MVA 
1.12 (1,890)   1.4 (2,400) 2.04 (3,468)   5.65 (9,605)  
Poly MVA Radiotherapy Published Studies
#1 - Poly MVA enhances efficacy of Radiation Treatments #2 - Poly MVA significantly reduces Radiation Damage 


What is the Potential for Vitamin D in Cancer Treatment?
Vitamin D deficiency has clearly been shown to be a risk factor in the development of multiple forms of cancer.
This scientific research indicates that maintaining high levels of vitamin D can prevent the progression of cancer & increase survival rates.

Each Cancer Patient needs to review these published studies

and then, test their 25-Hydroxy Vitamin D levels!



Circulating Vitamin D levels in the Blood
Dramatically Reduces Death Rate

* For each 10ng/ml increase in the blood level of vitamin D, the death rate from cancer would be reduced by 29%. The relationship between vitamin D and colorectal cancer is particularly strong. The death rate for colorectal cancer would be reduced by 49%.
Read Supporting Scientific Article)


Vitamin D Levels
Highest during Summer = Improves survival by 40%

* A Norwegian study showed that cancer patients diagnosed in the summer when vitamin D levels are highest had up to 40% better survival rates than patients diagnosed in the winter when vitamin D levels are at their lowest.
Read Supporting Scientific Article )


Low Vitamin D Levels
Greater chance of Death & Metastasis

* Breast cancer patients with low levels of vitamin D followed over 11 years had a 70% greater chance of dying and twice the rate of developing metastasis than patients with high levels of vitamin D.
Read Supporting Scientific Article )


Lung Cancer Patients
Higher levels = Dramatic increase in Survival

* Early stage lung cancer patients who were diagnosed in the summer and had the highest levels of vitamin D had a five-year survival of 73% compared to 30% for those diagnosed in the winter with low vitamin D levels.
(Read Supporting Scientific Article)


Lung - Colon - Prostate - Renal - Endometrial Cancers
Higher Vit D levels dramatically decreases Risk

* High vitamin D levels (based on latitude and UV exposure) also correlate with a decreased risk of developing lung cancer, a 45% and 65% reduction in men and women respectively. Similar effects have been demonstrated in colon, prostate, renal and endometrial cancer.
Read Supporting Scientific Article)

Advanced Colorectal Patients
Risk of death greatly Improved

* The risk of death for colorectal cancer patients with advanced disease but with high levels of vitamin D was reduced by over 60% compared to patients with low vitamin D levels.
Read Supporting Scientific Article)

Prostate Cancer Patients
7 Fold reduced risk of Death

* Prostate Cancer Patients with Vitamin D levels in the mid and high range had a 60% and 85% respectively reduced risk of death from the condition compared to patients with low levels of Vitamin D. This is almost a seven fold increase in the risk of death in those with low vs high vitamin D levels.
Read Supporting Scientific Article)


Click below for PRINTABLE PDF of Vitamin D Published Articles

7 Published Vitamin D Articles

25-Hydroxy Vitamin D Blood Test
Ask  your Doctor for this Test!

*Most Cancer Patients have Vitamin D blood levels

below < 40 ng/ml

Don't Be Fooled -- Order the Correct Test

There are two vitamin D tests -- 1,25(OH)D and 25(OH)D.
The correct test is 25(OH)D, also

The 25-hydroxy vitamin D blood test

25(OH)D is the better marker of overall D status. It is this marker that is most strongly associated with overall health.

Please note the difference between normal and optimal. You don't want to be average here; you want to be optimally healthy. Primitive man likely developed in tropical and sub-tropical conditions with large exposure to UV-B and its secondary consequence to skin exposure, vitamin D.

Primitive environmental availability of a nutrient does not necessarily establish the higher requirements, but these exposures would have influenced the evolution of the relevant physiology, and such concentrations should at least be considered presumptively acceptable.

Some experts may disagree with the following healthy ranges, but they are taken from healthy people in tropical or subtropical parts of the world, where they are receiving healthy sun exposures. It seems more than reasonable to assume that these values are in fact reflective of an optimal human requirement.


Cancer's Favorite Food - Found in Everything You Eat?
Posted By Dr. Mercola | August 27 2010

Check the ingredients of everything you eat or drink!

Beware of High Fructose Corn Syrup

Click below to read both articles from MSNBC and Reuters

MSNBC Article
Cancer Cells feed on fructose, study finds

Click here to Read Article

Reuters Article
Cancer Cells Slurp up fructose, US study finds

Click here to Read Article

Poly MVA Independent Lab testing of 8 Cancer Cell Lines
In 2007, KGK Science, Inc., an independent laboratory in Canada, examined the effects of POLY-MVA on 8 cancer cell lines.

These lines included:
1) Skin melanoma, human (SKMel-5)
2) Liver, hepatocellular carcinoma, human (Hep G2)
3) Lung, malignant melanoma, human (Malme-3M)
4) Mammary gland, ductal carcinoma, human (MDA-MB 435)
5) Prostate, left supraclavicular lymph node carcinoma, human (LNCaP)
6) Colon, colorectal adenocarcinoma, human (HT-29)
7) Human brain, glioblastoma; astrocytoma (U87)
8) Glioblastoma (HT-80)
POLY-MVA was administered at 3 different dosages and the number of cells was examined after 24, 48 and 72 hours following initial application. POLY-MVA was effective, to varying degrees, on the entire group of cell lines tested
(melanoma, liver, lung, breast, prostate, colon, astrocytoma and glioblastoma).
The varying effectiveness appears to be a consequence of the particular cell lines used and their associated degree of anaplasia.
The graph below demonstrates the benefit of POLY-MVA after 48 hours of initial exposure:
The Y-axis represents the number of cells per mL.
Poly MVA causes significant cell death after 48 Hours of exposure 
The table below illustrates the statistically significant level of cell death
(p must be equal to or less than 0.05) induced by POLY-MVA after 48 hours of initial exposure: 


Cancer Cell Type



Cell Line

Statistical Significance


Dosages (ug/ml)




100, 1000


Hep G2






100, 1000


MDA-MB 435










10, 100, 1000



p<0.05; p<0.01

10, 100; 1000




10, 100, 1000

Garnett McKeen In vitro Cancer Assays:
Garnett McKeen Laboratory Inc. (GML) chose to mimic the National Cancer Institute’s (NCI) cell screening protocol.

The following cell lines were selected from the NCI repository:

MCF-7 (breast adenocarcinoma), and A549 (lung non-small cell adenocarcinoma).


The data below represents the completion of the Breast Cancer (MCF-7), Ovarian Cancer (OVCAR-5) and Lung Carcinoma (A549) assay.


We have also completed assays using stage IV glioblastoma multiforme (H-80) and astrocytoma (H-4) brain tumor lines.


As noted below, all of the studies demonstrated significant cell death.


After 48 hours of exposure

Breast Cancer



Breast Cancer Cell Death after 48 Hours

Ovarian Cancer



Ovarian Cancer Cell Death after 48 Hours


Lung Cancer

(Non-Small Cell Carcinoma)

83.8% Percentage

Lung Cancer Cell Death after 48 Hours


Brain Tumor
96.3% Percentage
Brain Cancer Cell Death after 48 Hours
Brain Tumor
82.5% Percentage
Brain Cancer Cell Death after 48 Hours



For Doctors and Patients

Oncologist touts the benefits of Poly-MVA(LAMC)


James Forsythe, MD, HMD

Century Wellness Clinic in Reno, NV


"The long-term positive impact I have seen in our clinic is quite astounding. Since 2004, we've performed 3 outcome studies in over 1700 patients with Poly-MVA(LAMC).


Poly-MVA provides a significant difference as a stand-alone or Integrative Protocol and also continues to show outstanding impact for each patient's success & overall health."

Stage IV Study -  1,000 Patients

©2017 All Rights Reserved
The Poly MVA Survivors website is designed for educational purposes only, and is not engaged in rendering specific medical advice or professional services. The information provided through this website should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care.